Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | synuclein, alpha (non A4 component of amyloid precursor) | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | sphingolipid delta 4 desaturase/c-4 hydroxylase protein des2 family protein | 0.0219 | 0.1997 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0416 | 0.2082 |
Mycobacterium tuberculosis | Possible electron transfer protein FdxB | 0.0219 | 0.1997 | 0.5 |
Echinococcus multilocularis | Peptidase M, neutral zinc metallopeptidases, zinc binding site | 0.0219 | 0.1997 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0416 | 0.2082 |
Brugia malayi | Fatty acid desaturase family protein | 0.0219 | 0.1997 | 0.2532 |
Plasmodium vivax | stearoyl-CoA desaturase (acyl-CoA desaturase, faty acid desaturase), putative | 0.0828 | 0.7885 | 0.5 |
Loa Loa (eye worm) | fatty acid desaturase | 0.0219 | 0.1997 | 0.2532 |
Mycobacterium ulcerans | electron transfer protein FdxB | 0.0219 | 0.1997 | 0.5 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0828 | 0.7885 | 0.7358 |
Loa Loa (eye worm) | hypothetical protein | 0.0219 | 0.1997 | 0.2532 |
Mycobacterium ulcerans | linoleoyl-CoA desaturase, DesA3_2 | 0.0219 | 0.1997 | 0.5 |
Mycobacterium tuberculosis | Probable transmembrane alkane 1-monooxygenase AlkB (alkane 1-hydroxylase) (lauric acid omega-hydroxylase) (omega-hydroxylase) (f | 0.0219 | 0.1997 | 0.5 |
Echinococcus granulosus | Fatty acid desaturase type 1 | 0.0219 | 0.1997 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0219 | 0.1997 | 0.5 |
Loa Loa (eye worm) | FAT-3 protein | 0.0219 | 0.1997 | 0.2532 |
Trypanosoma brucei | fatty acid desaturase, putative | 0.1047 | 1 | 1 |
Plasmodium falciparum | stearoyl-CoA desaturase | 0.0828 | 0.7885 | 0.5 |
Onchocerca volvulus | 0.1047 | 1 | 1 | |
Loa Loa (eye worm) | acyl-CoA desaturase | 0.0828 | 0.7885 | 1 |
Brugia malayi | Delta5 fatty acid desaturase | 0.0219 | 0.1997 | 0.2532 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0416 | 0.2082 |
Mycobacterium ulcerans | transmembrane alkane 1-monooxygenase AlkB | 0.0219 | 0.1997 | 0.5 |
Mycobacterium ulcerans | linoleoyl-CoA desaturase, DesA3 | 0.0219 | 0.1997 | 0.5 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0828 | 0.7885 | 0.7358 |
Mycobacterium ulcerans | hypothetical protein | 0.0219 | 0.1997 | 0.5 |
Echinococcus multilocularis | Peptidase M, neutral zinc metallopeptidases, zinc binding site | 0.0219 | 0.1997 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0416 | 0.2082 |
Mycobacterium ulcerans | linoleoyl-CoA desaturase, DesA3 | 0.0219 | 0.1997 | 0.5 |
Brugia malayi | acyl-CoA desaturase | 0.0828 | 0.7885 | 1 |
Echinococcus granulosus | Sphingolipid delta4 desaturase DES1 | 0.0219 | 0.1997 | 1 |
Onchocerca volvulus | 0.1047 | 1 | 1 | |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0416 | 0.2082 |
Onchocerca volvulus | 0.0219 | 0.1997 | 0.1997 | |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0416 | 0.2082 |
Brugia malayi | Fatty acid desaturase family protein | 0.0219 | 0.1997 | 0.2532 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0416 | 0.2082 |
Mycobacterium tuberculosis | Probable conserved membrane protein | 0.0219 | 0.1997 | 0.5 |
Loa Loa (eye worm) | fatty acid desaturase | 0.0219 | 0.1997 | 0.2532 |
Echinococcus multilocularis | Fatty acid desaturase, type 1 | 0.0219 | 0.1997 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0416 | 0.0527 |
Leishmania major | fatty-acid desaturase, putative | 0.1047 | 1 | 1 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.1047 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0416 | 0.0527 |
Schistosoma mansoni | fatty acid desaturase | 0.0219 | 0.1997 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.8913 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.